Information  X 
Enter a valid email address

Consort Medical Plc (CSRT)

  Print      Mail a friend       Annual reports

Wednesday 20 November, 2019

Consort Medical Plc

Form 8 (OPD) (Consort Medical plc)

RNS Number : 1129U
Consort Medical PLC
20 November 2019
 

FORM 8 (OPD)

 

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1.         KEY INFORMATION

 

(a) Full name of discloser:

Consort Medical plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Consort Medical plc

(d) Is the discloser the offeror or the offeree?

Offeree

(e) Date position held:

19 November 2019

(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

N/A

 

 

2.         POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

ORDINARY SHARES OF 10P EACH


Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

     TOTAL:

Nil

-

Nil

-

 

(b)        Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3.         POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

3(a) Interests held by directors of Consort Medical PLC and their close relatives and related trusts (excluding options and awards set out below)

 

NAME

NUMBER OF ORDINARY SHARES

PERCENTAGE OF TOTAL ISSUED ORDINARY SHARE CAPITAL (%)(1)

Christopher Brinsmead

6,000

0.0122

Stephen Crummett

1,000(2)

0.0020

Charlotta Ginman

948

0.0019

Jonathan Glenn

183,762(3)

0.3723

Paul Hayes

12,438

0.0252

Andrew Hosty

1,597

0.0032

William Jenkins

1,625

0.0033

Ian Nicholson

2,378

0.0048

Notes

(1) Based on 49,364,234 shares in issue at 19 November 2019

(2) Shares held by Skerry Crummett.

(3) Includes 118,101 shares held by Janis Glenn.

 

3(b) Options and awards held by directors of Consort Medical plc in Consort Medical plc shares

 

(i)   Jonathan Glenn

 

Performance Share Plan 2015

Date of grant

Type of award

Number of shares under option

Exercise price

Exercise period

20 June 2017

Option

45,385

Nil

20 June 2020 - 19 June 2027

19 July 2018

Option

40,255

Nil

20 June 2023 - 18 July 2028

23 August 2019

Option

69,438

Nil

24 August 2024 - 22 August 2029

 

Deferred Bonus Plan 2010

Date of grant

Type of award

Number of shares under option

Exercise price

Exercise period

20 June 2017

Option

15,787

Nil

19 June 2020 - 29 July 2020

19 June 2018

Option

16,004

Nil

19 June 2021 - 29 July 2021

24 July 2019

Option

17,216

Nil

24 July 2022 - 2 September 2022

 

Sharesave

Date of grant

 

Type of award

Number of shares under option

Exercise price

Exercise period

24 July 2019

Option

1,162

£7.74

1 September 2022 - 28 February 2023

25 July 2017

Option

862

£10.44

1 September 2020 - 28 February 2021

 

 

(ii)  Paul Hayes

 

Performance Share Plan 2015

Date of grant

Type of award

Number of shares under option

Exercise price

Exercise period

20 June 2017

Option

29,990

Nil

20 June 2020 - 19 June 2027

19 July 2018

Option

25,952

Nil

20 June 2023 - 18 July 2028

23 August 2019

Option

67,150

Nil

24 August 2024 - 22 August 2029

 

Deferred Bonus Plan 2010

Date of grant

 

Type of award

Number of shares under option

Exercise price

Exercise period

19 June 2018

Option

8,629

Nil

19 June 2021 - 29 July 2021

24 July 2019

Option

9,966

Nil

24 July 2022 - 2 September 2022

 

Sharesave

Date of grant

Type of award

Number of shares under option

Exercise price

Exercise period

24 July 2019

Option

2,325

£7.74

1 September 2022 - 28 February 2023

 

 

 

4.         OTHER INFORMATION

 

(a)        Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

None

 

(b)        Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

None

 

(c)        Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

No

Supplemental Form 8 (SBL)

No

 

 

Date of disclosure:

20 November 2019

Contact name:

Andrew Jackson, Group General Counsel

Telephone number:

+44 (0) 1442 867920

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
FEEFEUFMSFUSEFF

a d v e r t i s e m e n t